Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

OMKAR PHARMACHEM vs DECIPHER LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    OMKAR PHARMACHEM DECIPHER LABS OMKAR PHARMACHEM/
DECIPHER LABS
 
P/E (TTM) x 116.1 3.6 3,263.7% View Chart
P/BV x 2.5 3.0 83.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 OMKAR PHARMACHEM   DECIPHER LABS
EQUITY SHARE DATA
    OMKAR PHARMACHEM
Mar-21
DECIPHER LABS
Mar-21
OMKAR PHARMACHEM/
DECIPHER LABS
5-Yr Chart
Click to enlarge
High Rs2141 50.3%   
Low Rs1618 88.6%   
Sales per share (Unadj.) Rs0.355.0 0.5%  
Earnings per share (Unadj.) Rs0.21.4 15.8%  
Cash flow per share (Unadj.) Rs0.22.2 10.0%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs8.613.6 63.4%  
Shares outstanding (eoy) m10.0810.10 99.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x68.40.5 12,725.0%   
Avg P/E ratio x83.321.3 391.5%  
P/CF ratio (eoy) x82.913.4 617.5%  
Price / Book Value ratio x2.12.2 97.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m185298 61.8%   
No. of employees `000NANA-   
Total wages/salary Rs m1473 0.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3556 0.5%  
Other income Rs m06 0.0%   
Total revenues Rs m3562 0.5%   
Gross profit Rs m035 0.6%  
Depreciation Rs m08 0.1%   
Interest Rs m112 4.9%   
Profit before tax Rs m021 -1.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-37 -34.7%   
Profit after tax Rs m214 15.8%  
Gross profit margin %8.16.3 128.7%  
Effective tax rate %714.734.5 2,069.0%   
Net profit margin %82.02.5 3,248.3%  
BALANCE SHEET DATA
Current assets Rs m1225 0.3%   
Current liabilities Rs m10173 5.6%   
Net working cap to sales %-332.19.4 -3,528.5%  
Current ratio x0.11.3 5.6%  
Inventory Days Days12,57277 16,370.2%  
Debtors Days Days365766 47.6%  
Net fixed assets Rs m93161 57.7%   
Share capital Rs m101101 99.8%   
"Free" reserves Rs m-1436 -39.6%   
Net worth Rs m87137 63.3%   
Long term debt Rs m067 0.0%   
Total assets Rs m94387 24.2%  
Interest coverage x0.42.8 13.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x01.4 2.0%   
Return on assets %3.06.7 44.6%  
Return on equity %2.610.2 24.9%  
Return on capital %0.216.2 1.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m018 1.2%  
From Investments Rs mNA-3 0.0%  
From Financial Activity Rs mNA40 -0.5%  
Net Cashflow Rs m055 0.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 0.0 34.2 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 100.0 65.8 151.9%  
Shareholders   3,561 39,657 9.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare OMKAR PHARMACHEM With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    CIPLA    AUROBINDO PHARMA    



Today's Market

Sensex Zooms 515 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian share markets rose today tracking the rally in US stocks after softer-than-expected US inflation data stoked speculation the Federal Reserve could pivot to a shallower pace of interest-rate hikes.